CARDIOPATA ISQUMICA Anlogos GLP-1 y reduccin incidencia de cncer Autor: Marcos Garca Aguado (Cardilogo clnico del Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Espaa) Fecha de publicacin: 26/05/2025 Categora: Controversia 4 minutos Este post incluye opiniones de su autor
Conclusion: Targeted Fat Cell Metabolism with AOD-9604 Understanding how AOD-9604 targets fat cells reveals a scientifically-grounded approach to body composition improvement through selective cellular mechanisms
What Are the Implications of New Anti-Obesity Drugs for Racial Disparities? KFF, 24 July 2024, www.kff.org/policy-watch/what-are-implications-of-new-anti-obesity-drugs-racial-dispari ties/
This increases the production of nitric oxide (NO), a potent vasodilator and signaling molecule that enhances blood flow and vessel permeability, further supporting tissue repair
[This] will profoundly impact our ability to provide valuable and much-needed support to innovators in the GLP-1 space, for the benefit of their patients, said Stephen Houldsworth, senior vice president and global head of Platform Management & Marketing at Basel-based CordenPharma
"We looked at things like assault
